Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas.
Clin Cancer Res. 2023 Jan 4;29(1):233-243. doi: 10.1158/1078-0432.CCR-22-2085.
Clin Cancer Res. 2023.
PMID: 36282277
KIF11 inhibitors filanesib and ispinesib inhibit meningioma growth in vitro and in vivo.
Jungwirth G, Yu T, Cao J, Eddine MA, Moustafa M, Warta R, Debus J, Unterberg A, Abdollahi A, Herold-Mende C.
Jungwirth G, et al. Among authors: eddine ma.
Cancer Lett. 2021 May 28;506:1-10. doi: 10.1016/j.canlet.2021.02.016. Epub 2021 Feb 27.
Cancer Lett. 2021.
PMID: 33652084
Item in Clipboard
Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In Vivo.
Yu T, Cao J, Alaa Eddine M, Moustafa M, Mock A, Erkut C, Abdollahi A, Warta R, Unterberg A, Herold-Mende C, Jungwirth G.
Yu T, et al. Among authors: alaa eddine m.
Cancers (Basel). 2021 Nov 24;13(23):5898. doi: 10.3390/cancers13235898.
Cancers (Basel). 2021.
PMID: 34885009
Free PMC article.
Item in Clipboard
Cite
Cite